CRSP

CRISPR Therapeutics AG

Contracts

Total Value

Stock Metrics

19.6%

Short % Float

11.5d to cover · Moderate squeeze

77.9%

Inst % Float

10 holders · 2026-06-30

ARK Investment Man

Top Holder

9.8% of float

96.0M sh

Public Float

15/100

Dilution Score

Low

641 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

15/100

LOW

Inst: 77.86% · Top: ARK Investment Management, LLC

Biotech Analytics

Gene Editing

54.76

Squeeze risk: MODERATE

Insider Buying0

Publications100

Dilution Risk15

Clinical Trials100

Short Interest50